Versuchen GOLD - Frei
Faster time to market with Continuous Direct Compression
Express Pharma
|July 2025
Development and production using Continuous Manufacturing
-
The production of medicines and food supplements is experiencing a real innovation boost thanks to Continuous Manufacturing processes. For a long time, manufacturers hesitated in the face of cost-intensive conversions, time-consuming revalidation and complex systems with large space requirements. However, Continuous Manufacturing is now proving that endto-end production can also be space-saving, uncomplicated and economical. With the FE CPS, Fette Compacting is underlining this development and at the same time positioning itself as an integrated process partner.
In order to make continuous manufacturing more economically attractive, Fette Compacting fundamentally reviewed the concept of continuous direct compression a few years ago. The original approach was still strongly oriented towards established principles of pharmaceutical processing and the combination of existing systems. In order to fully utilize the advantages of continuous direct compression, it was necessary to rethink the entire process and system design.
The resulting processing system FE CPS (Continuous Processing System) establishes a reliable, powerful and highly flexible technology for the continuous production of pharmaceutical and nutraceutical products. The principle of Direct Compression enables the immediate transfer of the powder: it is transferred from the dosing-mixing unit directly to the tablet press via a flexible transport system (Fig. 1). Unlike conventional processes with wet or dry granulation, this eliminates several process steps, significantly reducing space requirements, energy consumption and overall costs. The developers designed the system for a wide range of application scenarios: It processes a wide range of ingredients with a flexible throughput of between five and over 200 kilograms per hour.
Inline quality control Diese Geschichte stammt aus der July 2025-Ausgabe von Express Pharma.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Express Pharma
Express Pharma
Future opportunities in biologics and biosimilars will demand significant investment
Semaglutide's patent expiry in India in March 2026 has become the immediate trigger for the next wave of pharmaceutical development activity, but the larger opportunity goes well beyond semaglutide itself.
1 mins
April 2026
Express Pharma
Gandhi Automations elevates loading bay efficiency with advanced dock leveler solutions
Engineered systems from Gandhi Automations Pvt Ltd enhance safety, durability and seamless material flow
2 mins
April 2026
Express Pharma
Redefining humidity control in pharma manufacturing
Bry-Air systems reflect shift towards material-based humidity control in pharma manufacturing
2 mins
April 2026
Express Pharma
2026 amendments to NDCT Rules: Foreword to India's biosimilars story or a step too short?
Kosturi Ghosh, Partner, and Ajeya B G, Sr Associate, in the Corporate practice at Trilegal, assess India's 2026 NDCT amendments as a timely push for biosimilars, but not enough on their own. The article highlights that stronger policy clarity and ecosystem support will be critical to truly unlock growth.
4 mins
April 2026
Express Pharma
Optima advances digital twins to boost efficiency in pharmaceutical turnkey machines
Virtual testing, training and simulation tools enhance performance in complex manufacturing environments
7 mins
April 2026
Express Pharma
Complete environmental monitoring solution – testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
3 mins
April 2026
Express Pharma
Flexotherm heating tapes & cords
Typical Applications of Heating Tapes and Cords in Industrial Solvent Handling
1 mins
April 2026
Express Pharma
Safeguarding the pharma excipients supply chain
Adding excipient details to QR codes of the top 300 drugs may not be a tough task. But as CDSCO plans to expand QR codes to cover other critical drug categories in phases, all segments of the pharma value chain need to tighten their systems, analyses Viveka Roychowdhury
15 mins
April 2026
Express Pharma
This is only the beginning of a much larger global patent-cliff cycle
As the patent expiry of semaglutide is almost there in India, several Indian pharma firms are preparing to introduce generic versions, highlighting the sector's agility in responding to high-value loss-of-exclusivity opportunities.
1 min
April 2026
Express Pharma
Leading people in the age of Al
As Al reshapes pharma, HR leadership is being drawn into a deeper question that goes beyond technology to the future of people and work, finds Lakshmipriya Nair
8 mins
April 2026
Listen
Translate
Change font size
